Norway · Delayed Price · Currency is NOK Ensurge Micropower ASA Earnings Call Transcripts
Fiscal Year 2026
-
Record battery performance and reduced costs mark a pivotal quarter, with commercialization and scalable partnerships prioritized for 2026. Fixed cost restructuring and talent retention remain key challenges as the company advances toward high-value, AI-driven applications.
Fiscal Year 2025
-
Q4 was a pivotal transition with new leadership, a shift to product-led strategy, and significant cost reductions. The company is preparing for commercialization in 2026, focusing on platform validation, scalable production, and robust customer partnerships.
-
A multi-phase collaboration with Corning brings up to $15M in investment and deep technical integration, aiming to accelerate advanced battery development for AI, wearables, and medical devices. The partnership enhances credibility, scales production, and positions Ensurge for long-term growth.
-
A new CEO with a strong track record is steering the company toward growth by focusing on solid-state battery technology, scalable manufacturing, and a tiered product strategy. The company is well-positioned to benefit from AI-driven miniaturization trends and is actively engaging investors to support its next phase.
-
Transitioned from R&D to commercialization with a validated battery, strong customer interest, and a 150,000-unit order. Focus is on medtech and IoT, with new manufacturing lines and automation boosting yield and capacity. Commercial production of 28-layer batteries is targeted for summer 2024.
Fiscal Year 2024
-
Demand for advanced batteries is surging, with Ensurge's stainless steel roll-to-roll technology offering high energy density and safety for IoT and medical devices. Commercial deliveries are targeted for late 2025, with a focus on premium customers and joint development agreements.